Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Sophia Genetics Sa (SOPH)

Sophia Genetics Sa (SOPH)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 214,082
  • Shares Outstanding, K 63,338
  • Annual Sales, $ 40,450 K
  • Annual Income, $ -73,680 K
  • 60-Month Beta N/A
  • Price/Sales 5.32
  • Price/Cash Flow N/A
  • Price/Book 0.85
Trade SOPH with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/22
See More
  • Average Estimate -0.39
  • Number of Estimates 2
  • High Estimate -0.39
  • Low Estimate -0.39
  • Prior Year -0.34
  • Growth Rate Est. (year over year) -14.71%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.16 +71.76%
on 06/16/22
4.66 -20.47%
on 05/31/22
-0.60 (-13.92%)
since 05/27/22
3-Month
2.16 +71.76%
on 06/16/22
8.44 -56.04%
on 03/31/22
-4.65 (-55.62%)
since 03/29/22

Most Recent Stories

More News
SOPHiA GENETICS Publishes Results of 2022 Annual General Meeting

/PRNewswire/ -- SOPHiA GENETICS SA (Nasdaq: SOPH) ("the Company"), is pleased to announce the Annual General Meeting ("the Meeting") was held at the Company's...

SOPH : 3.71 (+9.76%)
SOPHiA GENETICS Publishes Results of 2022 Annual General Meeting

/CNW/ -- SOPHiA GENETICS SA (Nasdaq: SOPH) ("the Company"), is pleased to announce the Annual General Meeting ("the Meeting") was held at the Company's...

SOPH : 3.71 (+9.76%)
SOPHiA GENETICS Publishes Environmental, Social and Governance Impact Summary

/PRNewswire/ -- SOPHiA GENETICS SA (Nasdaq: SOPH) ("the Company"), today announced that the Company has published its first Environmental, Social and...

SOPH : 3.71 (+9.76%)
Sophia Genetics SA (SOPH) Q1 2022 Earnings Call Transcript

SOPH earnings call for the period ending March 31, 2022.

SOPH : 3.71 (+9.76%)
SOPHiA GENETICS Announces Nomination of Jean-Michel Cosséry to Board of Directors

/CNW/ -- SOPHiA GENETICS (Nasdaq: SOPH), a leader in data-driven medicine, today announced the nomination of Jean-Michel Cosséry to its Board of Directors. The...

SOPH : 3.71 (+9.76%)
NVS : 84.77 (+0.71%)
SOPHiA GENETICS Hits Milestone of One Million Genomic Profiles Analyzed by the SOPHiA DDM™ Platform

/CNW/ -- SOPHiA GENETICS (Nasdaq: SOPH), a leader in data-driven medicine, has reached the milestone of one million genomic profiles analyzed by its SOPHiA...

SOPH : 3.71 (+9.76%)
SOPHiA GENETICS to Announce Financial Results for the First Quarter of Fiscal 2022 on May 10, 2022

BOSTON and LAUSANNE, Switzerland, April 13, 2022 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH), a leader in data-driven medicine, today announced...

SOPH : 3.71 (+9.76%)
RSI Alert: Sophia Genetics (SOPH) Now Oversold

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical...

SOPH : 3.71 (+9.76%)
Sophia Genetics SA (SOPH) Q4 2021 Earnings Call Transcript

SOPH earnings call for the period ending December 31, 2021.

SOPH : 3.71 (+9.76%)
SOPHiA GENETICS Reports Fourth Quarter and Full Year 2021 Financial Results

Revenues Grew 40% for the Fourth Quarter and 42% for Full Year 20212022 Guidance Reaffirmed BOSTON and LAUSANNE, Switzerland, March 15, 2022 (GLOBE...

SOPH : 3.71 (+9.76%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

SOPHiA GENETICS SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It is the creator of the SOPHiA DDM(TM) Platform, a cloud-based SaaS platform capable of analyzing data and generating insights...

See More

Key Turning Points

3rd Resistance Point 4.71
2nd Resistance Point 4.26
1st Resistance Point 3.99
Last Price 3.71
1st Support Level 3.27
2nd Support Level 2.82
3rd Support Level 2.55

See More

52-Week High 19.80
Fibonacci 61.8% 13.06
Fibonacci 50% 10.98
Fibonacci 38.2% 8.90
Last Price 3.71
52-Week Low 2.16

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar